Madison J. Ferraro

MADISON FERRARO focuses her practice on white collar criminal defense and investigations, securities litigation, and complex commercial disputes. She has represented clients in matters before federal agencies, including the U.S. Department of Justice (DOJ) and U.S. Securities and Exchange Commission (SEC), as well as in federal and state courts and arbitration proceedings. Madison also has experience representing companies across a range of industries in venture capital financings, public offerings, and other corporate transactions.

Madison maintains an active pro bono practice spanning domestic violence advocacy and appellate litigation. Her pro bono work includes securing domestic violence restraining orders on behalf of survivors of domestic violence and contributing to amicus briefs addressing constitutional and criminal law issues before federal courts of appeals.

Madison earned her J.D. with high honors from Emory University School of Law, where she was elected to the Order of the Coif. While in law school, Madison served as a research assistant for Professor Ani Satz, J.D., Ph.D, and completed internships at the University of Pittsburgh Medical Center (UPMC), the Children’s Healthcare of Atlanta (CHOA) hospital system, and the Centers for Disease Control and Prevention (CDC). Madison also served as a student attorney at the Barton Center’s Legislative Advocacy Clinic, where she worked to reform child welfare laws in Georgia and promote justice for children.

Prior to attending law school, Madison worked as a program analyst at a national public health organization in Washington, D.C., where she focused on strengthening public health infrastructure in the United States.

• Novo Nordisk Inc. in U.S. ex rel. Siegel v. Novo Nordisk Inc., a False Claims Act action involving allegations of violations of the Anti-Kickback Statute and off-label promotion, resulting in a complete defense verdict.
• Corporate clients and professional services firms in DOJ and SEC investigations and related internal investigations involving allegations of accounting fraud, financial misrepresentations, bribery, kickbacks, and other corporate misconduct.
• Publicly traded companies and their executives in federal securities class actions alleging violations of federal securities laws.
• Private equity funds in disputes with limited partners.
• Companies in responding to shareholder demands for inspection of books and records under Section 220 of the Delaware General Corporation Law.
• Atia Vision Inc., a medical device company, develops modular presbyopia-correcting intraocular lenses, in its Series E financing led by Cormorant Asset Management with participation by The Capital Partnership, PA MedTech VC Fund, AMED Ventures, and Shifamed Angel investors.
• Flip, a next-generation social and live e-ecommerce platform, on its US$60 million Series B funding led by WestCap, with participation from Streamlined Ventures and other investors.
• Issuer’s counsel for Biodesix, Inc. in connection with its initial public offering and follow-on offerings.
• A U.S. Marine Corps veteran in obtaining an upgrade of his discharge characterization from Other Than Honorable to Honorable.